CSIRO Publishing Books Journals About Us Shopping Cart You are here: Journals > Reproduction, Fertility and Development   
Reproduction, Fertility and Development
  Vertebrate Reproductive Science & Technology
 
Search
 
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Board
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Special Issues
Research Fronts
Sample Issue
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
General Information
Review Article
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates

 Early Alert
Subscribe to our email Early Alert or RSS feeds for the latest journal papers.

 Connect with us
facebook   youtube

Training

Publication Workshops


 

Article << Previous     |     Next >>   Contents Vol 19(1)

31 EFFECT OF TREATMENT OF OVINE CYTOPLASTS WITH CAFFEINE ON THE TRANSLOCALIZATION OF HSP27 IN SOMATIC CELL NUCLEAR TRANSFER RECONSTRUCTED EMBRYOS

I. Choi, J.-H. Lee and K. H. S. Campbell

Reproduction, Fertility and Development 19(1) 134 - 134

Abstract

We have previously reported that treatment of enucleated ovine oocytes with 10 mM caffeine for 6 h increases the activities of maturation-promoting factor (MPF) and mitogen-activated protein kinase (MAPK) (Lee and Campbell 2006 Biol. Reprod. 74, 691–698). In addition, when used as cytoplast recipients for somatic cell nuclear transfer (SCNT), the resultant blastocyst stage embryos show an increase in total cell numbers. Furthermore, we have also found that gene expression profiles observed following caffeine treatment more closely resemble those of IVF embryos than non-treated SCNT embryos. In particular, heat shock protein 27 (HSP-27, a molecular chaperon was down-regulated in non-treated SCNT embryos. In contrast, in caffeine-treated SNCT embryos, levels of transcripts were similar to those of IVF embryos (Choi et al. 2006 Reprod. Fertil. Dev. 18, 122). Several studies on heat shock protein 25 (HSP-25)/HSP-27 demonstrated that HSP-27 was underexpressed in SCNT bovine embryos (Pfister-Genskow et al. 2005 Biol. Reprod. 72, 546–555), and phosphorylated HSP-25 becomes sub-localized in nucleus following heat shock condition in mouse embryos (Kim et al. 2002 Mol. Reprod. Dev. 61, 3–13). In cultured cells, HSP-25 phosphorylation was mediated by mitogen-activated protein kinase (MAPK), suggesting that nuclear-translocated HSP-25 might function to protect nuclear structure, thereby preventing apoptosis (Geum et al. 2002 J. Biol. Chem. 277, 19 913–19 921). In this study, we investigated the effects of caffeine treatment on the localization of HSP-27 by fluorescene immunocytochemistry in SCNT and control embryos. HSP-27 was detected primarily in the cytoplasm of non-treated SCNT embryos from the 1-cell stage onwards; however, some nulear staining was observed in some embryos. In contrast, in caffeine-treated SCNT embryos, a more intense immunostaining of HSP-27 was observed in the nucleus than in the cytoplasm. This result indicated that HSP-27 was phosphorylated and translocated into nucleus in SCNT embryos treated with caffeine. In addition, we also examined the levels of transcripts of upstream genes of HSP-27 such as p38MAPKs, and MAPK-activated protein kinase 5 (Mapkapk5) by semi-quantitative RT-PCR. The levels of Mapkapk5 and p38MAPKs transcriptional expression were constant among groups. These observations suggest that the effects mediated by caffeine on HSP-27 occur before the onset of zygotic transcription, are independent of gene expression, but are maintained until the blastocyst stage. Taken together, our results suggest that the down-regulated expression of HSP-27 in SCNT embryos may be linked with the increased incidence of programmed cell death. In contrast, the elevated expression of HSP-27 and increased nuclear translocation observed in caffeine-treated SCNT embryos may contribute to the increase in total cell number we have previously reported at the blastocyst stage.



Full text doi:10.1071/RDv19n1Ab31

© CSIRO 2007

 
 Export Citation
 Print
  
  
    


 
Top  Email this page
 
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2012